Attendee search 

Helsinn is a privately owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. Since 2012, Helsinn has been coordinating clinical and regulatory activities in China from Beijing and in 2017 established an office in Shanghai to pursue commercial activities. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland, and the U.S., as well as a product presence in approximately 190 countries globally.

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.

Max Zeller Söhne AG specialises in the development, production and marketing of phyto-pharmaceuticals with clinically proven efficacy, safety and tolerability. 

Zeller is a leader in the Swiss market for phyto-pharmaceuticals and one of the few companies that controls the entire value chain from seed to finished product. At the Zeller sites in Romanshorn and Uttwil (VitaPlant), there are 135 employees in diverse disciplines such as biology, agriculture, process engineering, pharmacy and medicine. Patients benefit from Zeller’s phyto-pharmaceuticals both in Switzerland and worldwide.